共 50 条
[5]
Armstrong TS, 2020, LANCET ONCOL, V21, pE97, DOI 10.1016/S1470-2045(19)30796-X
[7]
Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer
[J].
FRONTIERS IN IMMUNOLOGY,
2023, 14
[8]
Glioblastoma Immune Landscape and the Potential of New Immunotherapies
[J].
FRONTIERS IN IMMUNOLOGY,
2020, 11